Related by context. All words. (Click for frequent words.) 78 proteasome inhibitors 77 HCV protease inhibitors 75 JAK inhibitors 75 ENMD # 75 vascular disrupting agents 74 SERMs 74 multitargeted 74 proteasome inhibitor 74 Symadex 74 Xanafide 73 anticancer therapies 73 Archexin 73 anticoagulant reversing agent 73 PI3K inhibitors 72 CYT# potent vascular disrupting 72 Carfilzomib 72 HSP# inhibitor 72 TLR agonists 72 CCX# 72 protein kinase inhibitor 72 PARP inhibitors 72 AEG# 72 Onconase 72 kinase inhibitors 72 JAK inhibitor 72 Hsp# inhibitors 72 epothilone 72 Panzem R NCD 72 Aplidin 72 SARMs 72 oral prodrug 72 metaglidasen 72 histone deacetylase HDAC inhibitors 71 Epothilones 71 anti angiogenic agents 71 mTOR inhibitors 71 PXD# 71 EGFR inhibitors 71 IAP inhibitors 71 epigenetic therapies 71 orally administered inhibitor 71 CBLC# 71 Dapagliflozin 71 anticancer agents 71 dasatinib Sprycel 71 chemopreventive agents 71 cancer immunotherapies 71 novel peptide 71 Nanobodies 71 molecularly targeted 71 therapeutic monoclonal antibody 71 BRAF inhibitor 71 immune modulating 71 HDAC inhibitors 71 TRAIL receptor antibodies 71 tyrosine kinase inhibitor 71 preclinically 70 siRNA therapeutics 70 HGS# 70 Squalamine 70 erlotinib Tarceva ® 70 MEK inhibitor 70 PEG SN# 70 Pimavanserin 70 Smac mimetic 70 receptor tyrosine kinase inhibitor 70 polymerase inhibitors 70 PDE4 inhibitor 70 OMP #M# 70 targeting CD# 70 BCR ABL inhibitors 70 YONDELIS 70 Tyrima 70 selective kinase inhibitor 70 kinase inhibition 70 lapatinib Tykerb 70 HuLuc# 70 VDAs 70 investigational humanized monoclonal antibody 70 XmAb# 70 GPCR targets 70 Nanobody ® 70 vinca alkaloid 70 HDAC inhibitor 70 Angiolix 70 VEGF inhibitors 70 orally bioavailable 70 antisense inhibitors 70 thalidomide Thalomid 70 JAK2 inhibitors 70 IMA# 70 PI3K/mTOR 70 RGB # 70 ZK EPO 70 Vidofludimus 70 JAK2 inhibitor 70 INT# [002] 70 histone deacetylase inhibitor 70 antimitotic 70 Panzem R 70 Anticalins 70 PI3K inhibitor 70 ganetespib 70 Gefitinib 70 JAK1 70 p# inhibitor 70 alvespimycin 70 NEUGENE 70 cMET 69 Factor VIIa 69 delta isoform 69 JAK3 69 Azedra 69 vascular disrupting agent 69 enzastaurin 69 CCR9 antagonist 69 selective inhibition 69 anti CD# antibodies 69 Guanilib 69 OHR/AVR# 69 Sphingomab 69 pan HDAC inhibitor 69 pertuzumab 69 nucleoside analogs 69 favorable pharmacokinetic profile 69 telomerase inhibitor 69 liposomal formulation 69 imatinib Gleevec ® 69 HQK 69 mertansine 69 anticancer agent 69 isoform selective 69 Amplimexon 69 Personalized Immunotherapy 69 fluoroquinolone antibiotic 69 predictive biomarkers 69 anti CD3 69 TLR8 agonist 69 Anticalin R 69 myeloproliferative disorders 69 A3 adenosine receptor 69 Panzem 69 HDACi 69 biologic therapeutics 69 NNR Therapeutics 69 oxidative stress inducer 69 novel anticancer 69 kinase inhibitor 69 Zolinza 69 small molecule activators 69 Perifosine 69 DCVax R 69 TLR9 agonist 69 Pertuzumab 69 depsipeptide 69 Mipomersen 69 Hsp# inhibition 69 Smac mimetics 69 tyrosine kinase inhibitors 69 tubulin inhibitor 69 novel immunomodulatory 69 ARRY # 69 Maribavir 69 non nucleoside 69 THR beta agonist 69 ErbB3 HER3 69 synthetic retinoid 69 chemotherapeutics 69 LNP formulations 69 PI3K/Akt pathway inhibitor 69 Sym# 69 selective immunoproteasome inhibitor 69 Gleevec resistant 69 RH1 69 Anticalin 69 TELINTRA 69 demonstrated antitumor activity 69 renin inhibitors 69 PDE4 inhibitors 69 AKT inhibitor 69 humanized monoclonal antibodies 69 imatinib Gleevec 69 therapeutic monoclonal antibodies 69 immune stimulatory 69 YONDELIS R 69 XL# XL# 69 Kinase inhibitors 69 highly selective inhibitor 69 OXi# 68 LEP ETU 68 antisense drugs 68 NNRTIs 68 PKC# 68 GSK3B 68 angiogenesis inhibitors 68 TLR9 agonists 68 Deforolimus 68 kidney urologic 68 nucleoside analogues 68 insulin sensitizers 68 anticancer therapeutics 68 orally dosed 68 entinostat 68 IMC A# 68 Vorinostat 68 PNP inhibitor 68 TPI ASM8 68 interferon IFN 68 OncoVEX GM CSF 68 MAGE A3 ASCI 68 CCR5 antagonist 68 sodium glucose cotransporter 68 TG# [003] 68 oral antiviral 68 echinocandins 68 cytotoxics 68 Dasatinib 68 tiapamil 68 CYC# 68 BAY #-# 68 Adnectin 68 Traficet EN 68 OncoVEX 68 HGS ETR1 68 tranilast 68 immunomodulator 68 interferon lambda 68 TLR8 68 #ME# 68 Exelixis compounds 68 PARP inhibitor 68 NTDDS 68 PORxin TM 68 AQ4N 68 protein kinase inhibitors 68 regorafenib 68 gamma secretase inhibitors 68 gefitinib Iressa 68 beta interferons 68 p# inhibitors 68 erlotinib Tarceva 68 MGCD# [001] 68 oral picoplatin 68 synthetic siRNA 68 personalized immunotherapy 68 immunotherapeutics 68 Talabostat 68 immune modulators 68 angiogenesis inhibitor 68 cediranib 68 immunomodulatory 68 Bafetinib 68 peripherally acting 68 CB1 antagonists 68 Nexavar ® 68 Locked Nucleic Acid LNA 68 VersaFilm 68 rxRNA 68 oncolytic 68 antisense drug 68 ulimorelin 68 IMiDs ® 68 potent antiproliferative 68 antisense oligonucleotides 68 myelofibrosis polycythemia vera 68 GRN#L 68 CA4P 68 deforolimus 68 endothelin antagonist 68 BiTE 68 neuroprotective properties 68 direct thrombin inhibitors 68 molecular biomarkers 68 anticancer compounds 68 oral anticancer 68 immunotherapeutic 68 enzyme inhibitors 68 CORT # 67 neratinib 67 radiation sensitizer 67 Fludara ® 67 delafloxacin 67 nucleotide analogs 67 immunomodulatory therapy 67 IAP inhibitor 67 selective antagonists 67 siRNA therapeutic 67 CDP# 67 Src inhibitors 67 Vandetanib 67 ALK inhibitors 67 signal transduction inhibitor 67 small molecule tyrosine 67 oral proteasome inhibitor 67 resolvins 67 BRAF inhibitors 67 mTOR inhibitor 67 investigational therapies 67 Blinatumomab 67 Aviptadil 67 selective inhibitors 67 NXL# 67 Preclinical studies suggest 67 visilizumab 67 MyVax R 67 cytoprotective 67 myeloproliferative diseases 67 Lenocta 67 antisense compounds 67 talabostat 67 bortezomib Velcade 67 BRAF kinase 67 CCR5 antagonists 67 #D#C# 67 anticancer compound 67 PIK3CA 67 selective androgen receptor modulators 67 vemurafenib 67 Virulizin ® 67 TAFA# 67 CDDO Im 67 Voreloxin 67 Tamibarotene 67 Thiovir 67 RNAi therapeutic targeting 67 Aurora kinase 67 Icatibant 67 epothilones 67 vidofludimus 67 triterpenoids 67 Temsirolimus 67 hypoxia activated prodrug 67 INCB# [001] 67 Anidulafungin 67 rNAPc2 67 cilengitide 67 cytotoxic agents 67 AMPK activators 67 amrubicin 67 PRT# 67 ASONEP 67 macrolide antibiotics 67 investigational monoclonal antibody 67 deacetylase inhibitors 67 drug ISA# 67 CD# antibody [001] 67 anti angiogenic drugs 67 trastuzumab DM1 T DM1 67 Litx 67 Darinaparsin 67 GW# [003] 67 prostanoid 67 Zybrestat 67 HIV integrase inhibitors 67 Nanobody 67 bevacizumab Avastin ® 67 IMiDs 67 brostallicin 67 anti fibrotic 67 neuronal nicotinic receptors NNRs 67 Fc fusion protein 67 elotuzumab 67 CRLX# 67 Seliciclib 67 tubulin inhibitors 67 polyketides 67 forodesine 67 selective orally bioavailable 67 histone deacetylase HDAC 67 pharmacokinetic interactions 67 endothelin receptor antagonists 67 Fodosine 67 JAK#/JAK# 67 Pazopanib 67 xenograft models 67 EGFR HER2 67 EGFR tyrosine kinase inhibitors 67 lomitapide 67 Anticalins R 67 inhibit metastasis 67 Vidaza R 67 PEGylated interferon 67 Tarvacin TM 67 Omacetaxine 67 histone deacetylase inhibitors 67 Ceflatonin 67 GMX# 67 FK# 67 HDAC inhibition 67 IMC #B 67 pharmacological chaperone 67 PSN# [002] 67 Pathway Inhibitor 67 orally bioavailable mimics 67 small molecule inhibitors 67 eprotirome 67 Myolimus 67 radezolid 67 nucleosides 67 adipiplon 67 Afatinib 67 antitumoral 67 geldanamycin 67 TLR Therapeutics 67 FLT3 67 XmAb 67 Vidaza ® 67 non nucleoside HCV 66 CEQ# 66 telomerase inhibitors 66 polymerase inhibitor 66 ATL# [002] 66 ocular formulation 66 Cloretazine VNP#M 66 somatostatin analogue 66 CD# antibodies 66 Bortezomib 66 prodrugs 66 humanized antibodies 66 volociximab 66 immunotherapeutic agent 66 mitogen activated ERK kinase 66 UPLYSO 66 ATL/TV# 66 multi kinase inhibitor 66 Interferon alpha 66 DXL# 66 chemopreventive agent 66 Atiprimod 66 TBC# 66 MTP inhibitor 66 Solazed TM 66 antagomirs 66 prostone 66 antiangiogenic agents 66 panitumumab Vectibix 66 small molecule defensin 66 peptidic 66 Ganetespib 66 Aurora kinase inhibitor 66 GPR# agonists 66 topical formulations 66 nucleoside analog 66 HepDirect 66 ErbB3 66 R#/MEM # 66 ospemifene 66 biologic therapies 66 Fleximer 66 otelixizumab 66 TOCOSOL Camptothecin 66 nucleoside analogue 66 Telatinib 66 Erlotinib 66 targeted radiotherapeutic 66 Serdaxin 66 anti amnesic 66 CR# vcMMAE 66 RNA antagonists 66 candidate deforolimus 66 mGluR2 NAM 66 IMiDs R 66 DOS# 66 sorafenib tablets 66 leading oral taxane 66 LHRH antagonists 66 Proxinium TM 66 ProLindac 66 PRTX 66 immunological diseases 66 uric acid lowering 66 antiviral compounds 66 thiazolides 66 CD# monoclonal antibody 66 anticancer therapy 66 histone methyltransferases HMTs 66 obatoclax 66 acadesine 66 Anticalin ® 66 immune modulatory 66 antifolates 66 mAbs 66 XYOTAX TM 66 cyclophilin inhibitor 66 chemotherapeutic drug 66 HDACs 66 candidate CRLX# 66 Taxanes 66 siRNA compounds 66 Akt inhibitor 66 pegylated interferons 66 Annamycin 66 defensin mimetic antibiotic 66 Tasimelteon 66 NF kB pathway 66 selective modulator 66 Cethrin R 66 mimetics 66 ixabepilone 66 immunotherapeutic vaccine 66 alkylating agent 66 gamma secretase inhibitor 66 antiproliferative effects 66 immunotoxins 66 HuMax EGFr 66 antiangiogenesis 66 Curaxin 66 Vidaza azacitidine 66 potently inhibit 66 IL# PE 66 Bezielle 66 EGFR TKIs 66 vorinostat 66 chemotherapeutic agents 66 nucleoside 66 peptide antigens 66 nilotinib Tasigna ® 66 rxRNA ™ compounds 66 LY# [003] 66 NovaBay Aganocide compounds 66 potent anticancer 66 Aliskiren 66 CTLA4 Ig 66 HSP# inhibitors 66 anti angiogenic therapy 66 gemcitabine Gemzar 66 microtubule targeting 66 immunomodulation 66 inhibit EGFR 66 atacicept 66 flavopiridol 66 ADP receptor antagonist 66 reversible inhibitor 66 HGS ETR2 66 paclitaxel Taxol 66 proprietary LNA 66 small molecule glucokinase 66 ddRNAi 66 imatinib resistance 66 PI3 kinase 66 Hedgehog inhibitor 66 potent inhibitors 66 PARP inhibition 66 DU #b 66 SAR# [002] 66 immunotherapeutic approaches 66 Amrubicin 66 preclinical efficacy 66 AAG geldanamycin analog 66 CCR2 66 integrase inhibitor 66 Anticalins ® 66 eniluracil 66 S/GSK# 66 ATL# [001] 66 EOquin 66 vaccines oncolytic virus 66 OXIGON TM 66 Triapine 66 Sudhir Agrawal D.Phil 66 Ridaforolimus 66 therapeutic mAbs 66 Bendavia 66 CDK inhibitor 66 enzyme inhibitor 66 KSP inhibitor 66 vinca alkaloids 66 AMN# [001] 66 PPARγ 66 Aganocide 66 Aurora Kinase 66 CRTH2 66 MMP inhibitors 66 DermaVir Patch 66 CB2 receptor 66 humanized monoclonal antibody 66 peptide conjugated 66 telomerase therapeutic 66 Neuradiab 66 novel oral anticoagulant 66 immunomodulating 66 EndoTAG TM 66 Apoptone 66 TKM ApoB 66 Cintredekin Besudotox 66 monoclonal antibody MAb 66 ceftazidime 66 tanespimycin 66 antiangiogenic 66 investigational compounds 66 humanized monoclonal 66 Imprime PGG 66 L BLP# 66 leukotriene receptor antagonist 66 Silodosin 66 RNA antagonist 66 tkRNAi technology 66 AEGR 66 radionuclide therapy 66 FOLOTYN ® 66 histone deacetylases 66 GVAX ® 65 BioVant 65 TriRima 65 antithrombotic 65 inhibiting tumor 65 demethylating agent 65 velafermin 65 anti angiogenic agent 65 oxazolidinone 65 Leukine ® 65 favorable pharmacokinetic 65 cleavable linker 65 Elagolix 65 REP# 65 azole 65 ganaxolone 65 hematological cancers 65 ESBA# 65 trastuzumab Herceptin 65 PGL# 65 cytostatic 65 novel VDA molecule 65 TOCOSOL 65 HCV protease 65 Monoclonal antibody 65 Zoraxel 65 Dicer Substrate Technology 65 DACH platinum 65 Romidepsin 65 incyclinide 65 Genz # 65 calcineurin inhibitors 65 selective kinase inhibitors 65 sodium glucose transporter 65 AtuRNAi 65 Intravenous CP 65 pomalidomide 65 Irinotecan 65 oncolytic virus therapies 65 Nanobody R 65 zanolimumab 65 oncolytic virus 65 CCR5 inhibitor 65 azoles 65 tezampanel 65 immuno modulatory 65 Eraxis 65 TOCOSOL Paclitaxel 65 ISIS # 65 NEUGENE antisense 65 rxRNA TM compounds 65 selectively inhibits 65 combinability 65 K ras mutations 65 Anavex #-# 65 Panzem NCD 65 TRV# [001] 65 Hsp# Inhibitor 65 indibulin 65 Aurexis 65 immunotoxin 65 beta 1a 65 shRNA libraries 65 Epratuzumab 65 ProMune 65 AVI NEUGENE 65 Cloretazine ® 65 Crizotinib 65 PSN# [001] 65 MEK inhibitor RDEA# 65 nanoviricides 65 tramiprosate Alzhemed TM 65 Poly ICLC 65 Insegia 65 XL# anticancer compounds 65 FGFR 65 nucleoside reverse transcriptase inhibitor 65 HCD# [002] 65 Sorafenib Nexavar 65 chimeric monoclonal antibody 65 Exelixis XL# 65 COMT inhibitors 65 vaccine GRNVAC1 65 Anthracycline 65 pro angiogenic 65 gastrin 65 XL# XL# XL# XL# 65 effector function 65 targeted antifolate 65 Allovectin 7 ® 65 lipid nanoparticles 65 2 methoxyestradiol 65 selective receptor agonist 65 LymphoStat B belimumab 65 gastro intestinal inflammation 65 peptidomimetic 65 modulator SERM 65 ZFPs 65 anti leukemic 65 HCV protease inhibitor 65 alefacept 65 phase IIb clinical 65 EGFR antibodies 65 Aflibercept 65 ProLindac TM 65 Novolimus 65 mecamylamine 65 Pharmos proprietary 65 Curaxins 65 MET amplification 65 tigecycline 65 highly selective endothelin 65 immune modulator 65 Dalbavancin 65 Civacir 65 Isis antisense 65 sorafenib Nexavar 65 MultiStat 65 CDK inhibitors 65 etanercept Enbrel 65 Tß4 65 preclinical xenograft models 65 HuMax TAC 65 XP #L 65 ghrelin antagonist 65 HuMax CD4 65 Pralatrexate 65 ALN TTR 65 humanized anti 65 forodesine hydrochloride 65 bendamustine 65 immunomodulators 65 Zoraxel TM 65 cannabinor 65 uricase 65 EGFr 65 histone deacetylase HDAC inhibitor 65 NEUMUNE 65 idarubicin 65 Cerashield 65 Novasome R 65 Dual Opioid TM 65 HIV integrase inhibitor 65 ALN PCS 65 echinocandin 65 Tofacitinib 65 Affibody ® molecules 65 Bucindolol 65 humanized antibody 65 reslizumab 65 synthetic peptides 65 catalytic antioxidant compounds 65 Tesetaxel 65 Abiraterone 65 5 HT3 receptor 65 oncolytic viruses 65 anti EGFR antibody 65 humanised antibody 65 R roscovitine 65 Selective Electrochemical Tumor Ablation 65 SNT MC# 65 Abiraterone acetate 65 Nanobodies ® 65 nilotinib Tasigna 65 antisense inhibitor 65 Olaparib 65 antiangiogenesis therapies 65 Nektar proprietary 65 Curaxin CBLC# 65 oral taxane 65 Marqibo TM 65 IL# PE#QQR 65 OMNARIS HFA 65 Kinases 65 MDV# 65 Phase #b/#a clinical 65 integrase inhibitors 65 CTAP# Capsules 65 demethylating agents 65 atrasentan 65 Presents Preclinical Data 65 pharmacokinetic properties 65 MNTX 65 paclitaxel Taxol ® 65 rBChE 65 Novosom 65 Cx# [002] 65 small molecule agonists 65 bexarotene 65 PPAR gamma agonists 65 Pradefovir 65 Ceflatonin R 65 BAL# [001] 65 HDAC 65 dAbs 65 Pentad TM 65 LY# [002] 65 tipifarnib 65 Cleviprex TM clevidipine 65 platinum chemotherapeutic 65 DXL TM 65 Factor Xa inhibitor 65 fusion enhancers 65 Modrenal R 65 selective androgen receptor modulator 65 Dyax phage display 65 LT NS# 65 NuMimetic TM 65 cyclophilin inhibitors 65 GV# [001] 65 Cloretazine 65 tubulin binding 65 Provecta TM 65 TNF inhibitors 65 diagnostic biomarkers 65 Tarvacin 65 clinically validated targets 65 prescribed proton pump 65 aripiprazole Abilify 65 receptor antagonists 65 Tezampanel 64 Elotuzumab 64 sunitinib malate 64 Epidermal Growth Factor Receptor 64 SIRT1 activators 64 Aganocide ® 64 TREANDA 64 Bicifadine 64 OMAPRO 64 tumor subtypes 64 peroxisome proliferator activated 64 LE DT 64 GAP #B# 64 acyclovir Lauriad R 64 menadione 64 LentiVector technology 64 humanised monoclonal antibody 64 afamelanotide 64 IRX 2 64 investigational pan BCR 64 ONCONASE R 64 SGLT inhibitors 64 NS#/#A protease 64 refractory metastatic 64 OvaRex R 64 exon skipping 64 huC# DM4 64 PDE# 64 elvitegravir 64 ARIKACE ™ 64 Aplidin R 64 ABL inhibitor 64 antimetastatic 64 docetaxel Taxotere ® 64 oncology therapeutics 64 Sapacitabine 64 Kevetrin ™ 64 Clofarabine 64 Ixabepilone 64 protein tyrosine phosphatases 64 Interferon beta 64 Erbitux cetuximab 64 CG# [003] 64 evaluating tivozanib 64 druggable targets 64 molecularly targeted therapies 64 tivozanib 64 Cylene 64 SILENOR 64 HCV polymerase inhibitors 64 Stapled Peptide 64 Octreotide 64 Glufosfamide 64 preclinical compounds 64 #HT#A 64 MGd 64 panobinostat 64 Etubics 64 HuCNS SC ® 64 Teplizumab 64 PHX# 64 Talactoferrin 64 mGluR5 antagonist 64 Ramoplanin 64 Apaziquone 64 modulates Akt 64 ALK inhibitor 64 R sorafenib tablets 64 MAbs 64 Targretin 64 castrate resistant prostate cancer 64 oral Factor Xa 64 Nanobodies R 64 Cyclosert 64 LHRH receptor positive 64 IgG1 antibody 64 Angiocept 64 IGF 1R 64 ibudilast 64 IMP# 64 retinoid 64 protein mTOR 64 Imatinib 64 Pagoclone 64 monoclonal antibody therapies 64 small molecule modulators 64 antiviral therapies 64 trabectedin 64 LibiGel ® 64 romazarit 64 liposome encapsulated 64 plasma kallikrein inhibitor 64 LEUKINE 64 Factor Receptor 64 MTP inhibitors 64 MAb 64 pharmacodynamic markers 64 bevacizumab Avastin 64 neovascular diseases 64 AP# [003] 64 receptor inhibitor 64 daptomycin 64 Campath ® 64 pharmacodynamic properties 64 CINQUIL 64 Cloretazine R 64 hematological tumors 64 benzimidazole 64 VTAs 64 Celator 64 galiximab 64 Granulocyte Colony Stimulating Factor 64 anticancer drugs 64 antitumour 64 next generation URAT1 64 VitiGam 64 BZL# 64 peptibody 64 Poly ICR 64 chemotherapeutic drugs 64 JAK2 kinase 64 Endotis 64 RNAi therapeutic targeting PCSK9 64 HGS ETR1 mapatumumab 64 biologic therapy 64 CB2 selective 64 Revlimid lenalidomide 64 antiarrhythmic 64 trastuzumab DM1 64 Multimeric 64 axitinib 64 Daclizumab 64 exemestane Aromasin 64 LPM TM 64 mda 7 64 TRIOLEX HE# APOPTONE HE# 64 subtype selective 64 SCH # 64 ThermoDox R 64 HepDirect R 64 vivo fluorescence imaging 64 proprietary PEGylation 64 Anthracyclines 64 SUTENT ® 64 Evoltra ® 64 novel antibody therapeutics 64 mGluR5 antagonists 64 CINOD 64 rituximab Rituxan 64 UsiRNAs 64 Fludarabine 64 FOLFOX6 chemotherapy regimen 64 anti angiogenic therapies 64 EGF receptor 64 Novartis Gleevec 64 antibody fragment 64 Combo Stent 64 M2 subunit 64 sulfonylhydrazine class 64 systemically administered 64 hematological malignancies 64 drug zotarolimus 64 VAPRISOL 64 Onco TCS 64 HDAC Inhibitor 64 oral gallium 64 NP2 Enkephalin 64 novel topoisomerase 64 GRASPA ® 64 Imatinib mesylate 64 angiogenesis inhibition 64 fosbretabulin 64 selective inhibitor 64 BAL# [002] 64 generation purine nucleoside 64 Immunotherapeutic 64 PI3 kinase inhibitors 64 IMiD